Ascites
📧 Sign up to get email alerts when something new happens for Ascites.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2026-07-23Clinical Trial Results: Efficacy, Safety and Tolerability of VS-01 in Adult Patients With Acute-on-Chronic Liver Failure and Ascites (UNVEIL-IT)® [Phase 2]
Phase 2 trial evaluating VS-01 in adults with acute-on-chronic liver failure and ascites; study terminated with posted results.
-
CLINICAL_TRIALS trial_result · 2026-04-13Clinical Trial Update: Endothelin Receptor Antagonism With Ambrisentan to Treat Hepatorenal Syndrome [Phase 2]
Phase 2 trial evaluating ambrisentan, an endothelin receptor antagonist, for hepatorenal syndrome; the study is currently active but not rec…
-
CLINICAL_TRIALS trial_result · 2026-04-09Clinical Trial Update: Apixaban-PK Trial: Preventing Portal Hypertension Complications in Cirrhosis [Phase 4]
Phase 4 pharmacokinetic study of apixaban to prevent portal hypertension complications in cirrhosis is currently recruiting.
-
CLINICAL_TRIALS trial_result · 2026-03-12Clinical Trial Update: PMCF Study of the CE-marked Drainova® ArgentiC Catheter
This PMCF study of the CE-marked Drainova ArgentiC Catheter by ewimed GmbH has completed. It evaluated its use for pleural effusion (includi…
-
CLINICAL_TRIALS trial_result · 2026-03-10Clinical Trial Update: Phase II/III of Recombinant Human Serum Albumin [Phase 2, Phase 3]
A Phase II/III clinical trial evaluating recombinant human serum albumin for cirrhotic ascites has completed.
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS trial_result · 2026-01-14Clinical Trial Update: Efficacy, Safety and Tolerability of VS-01 in Adult Patients With Acute-on-Chronic Liver Failure and Ascites (UNVEIL-IT)® [Phase 2]
Phase 2 study of VS-01 in adults with acute-on-chronic liver failure and ascites has been terminated. No further results are being reported …
-
CLINICAL_TRIALS trial_result · 2025-07-22Clinical Trial Update: A Pilot Trial to Test the Feasibility of Utilizing Home Blood Pressure Monitoring to Optimize the Administration of Midodrine Among Decompensated Cirrhosis Patients [NA]
A pilot trial evaluating the feasibility of using home blood pressure monitoring to optimize midodrine dosing in patients with decompensated…
-
CLINICAL_TRIALS trial_result · 2025-07-18Clinical Trial Update: Lung Point of Care Ultrasound to Guide Albumin Administration in Cirrhosis [Phase 3]
A Phase 3 trial evaluating whether point-of-care lung ultrasound can guide albumin administration in cirrhosis has completed.
-
CLINICAL_TRIALS trial_result · 2025-06-06Clinical Trial Update: Effects of Long-Term Administration of Human Albumin in Participants With Decompensated Cirrhosis and Ascites [Phase 3]
Phase 3 trial evaluating long-term administration of human albumin in people with decompensated cirrhosis and ascites has completed and resu…
-
CLINICAL_TRIALS trial_result · 2025-02-14Clinical Trial Update: Comparative Study of Secondary Prophylaxis for SBP [Phase 4]
Phase 4 clinical trial comparing secondary prophylaxis strategies for spontaneous bacterial peritonitis has completed.
-
CLINICAL_TRIALS trial_result · 2025-01-16Clinical Trial Update: Evaluation of Copeptin in Patients With Cirrhosis and Ascites [NA]
Clinical trial evaluating the biomarker copeptin in patients with cirrhosis and ascites has completed.
-
CLINICAL_TRIALS trial_result · 2024-12-13Clinical Trial Update: Evaluation of Hemodynamic Parameters Following Transjugular Intrahepatic Portosystemic Shunt (TIPS) [NA]
The clinical trial evaluating hemodynamic parameters following transjugular intrahepatic portosystemic shunt (TIPS) in patients with refract…
-
CLINICAL_TRIALS trial_result · 2024-12-11Clinical Trial Update: Achieving Portal Access With Scorpion Post-Approval Study (APASS) [NA]
Post-approval study APASS evaluating the Scorpion device for portal access in patients with portal hypertension and liver disease was termin…
-
CLINICAL_TRIALS trial_result · 2024-08-27Clinical Trial Update: Transjugular Intrahepatic Portosystemic Shunts Improve Survival in Patients With Cirrhosis and Recurrent Ascites
A completed clinical trial suggests that transjugular intrahepatic portosystemic shunts (TIPS) improve survival in patients with cirrhosis a…
-
CLINICAL_TRIALS trial_result · 2024-05-08Clinical Trial Update: A Study for Evaluation of BIV201 to Reduce Ascites and Complications in Patients With Cirrhosis and Refractory Ascites [Phase 2]
Phase 2 study evaluating BIV201 to reduce ascites and complications in patients with cirrhosis and refractory ascites has been terminated.
-
CLINICAL_TRIALS trial_result · 2024-03-06Clinical Trial Update: The BRAINFOOD Trial to Prevent Recurrent Hepatic Encephalopathy. [NA]
A completed clinical trial (BRAINFOOD) investigating prevention of recurrent hepatic encephalopathy in patients with cirrhosis and ascites; …
-
CLINICAL_TRIALS trial_result · 2023-12-15Clinical Trial Update: A Study of OCE-205 in Participants With Cirrhosis With Ascites Who Developed Hepatorenal Syndrome-Acute Kidney Injury [Phase 2]
Phase 2 trial assessing OCE-205 in participants with cirrhosis and ascites who developed hepatorenal syndrome-acute kidney injury has comple…
-
CLINICAL_TRIALS trial_result · 2023-04-13Clinical Trial Update: Allopurinol Versus Atorvastatin to Prevent Complications of Liver Cirrhosis [Phase 2, Phase 3]
A Phase 2/Phase 3 clinical trial comparing allopurinol to atorvastatin for preventing complications in liver cirrhosis and hepatic encephalo…
-
CLINICAL_TRIALS trial_result · 2022-11-29Clinical Trial Update: Empagliflozin as a Novel Therapy in Refractory Ascites [Phase 2, Phase 3]
A clinical trial update reports empagliflozin as a novel therapy for refractory ascites in hepatic disease, with Phase 2 and Phase 3 complet…
-
CLINICAL_TRIALS trial_result · 2022-11-21Clinical Trial Update: Rifaximin Prophylaxis for Spontaneous Bacterial Peritonitis and Hepatorenal Syndrome in Cirrhotic Patients [Phase 2]
Phase 2 trial update on rifaximin prophylaxis for spontaneous bacterial peritonitis and hepatorenal syndrome in cirrhotic patients with asci…
-
CLINICAL_TRIALS trial_result · 2021-09-05Clinical Trial Update: Sodium-glucose Linked Transporter 2 (SGLT-2) Inhibitors in Recurrent Ascites: a Pilot RCT [Phase 2]
A Phase 2 pilot randomized trial evaluating SGLT-2 inhibitors for recurrent ascites in cirrhosis, currently with unknown status.
-
CLINICAL_TRIALS trial_result · 2021-07-13Clinical Trial Update: Continuous Infusion Terlipressin for Patients With Cirrhosis and Refractory Ascites [Phase 2]
Phase 2 trial update for continuous infusion terlipressin in patients with cirrhosis and refractory ascites has completed with posted result…
-
CLINICAL_TRIALS trial_result · 2020-11-09Clinical Trial Update: Midodrine and Albumin in Patients With Refractory Ascites [Phase 3]
Phase 3 clinical trial update involving midodrine and albumin for patients with refractory ascites.
-
CLINICAL_TRIALS trial_result · 2020-01-09Clinical Trial Update: The Effect of Terlipressin on Recovery of Liver Function After Hepatectomy [Phase 3]
Phase 3 clinical trial assessing terlipressin for recovery of liver function after hepatectomy, with listed conditions including terlipressi…
-
CLINICAL_TRIALS trial_result · 2019-06-26Clinical Trial Update: Effects of Long Term Albumin 20% Administration in Patients With Cirrhosis and Ascites. [Phase 4]
Phase 4 trial update on long-term administration of Albumin 20% in patients with cirrhosis and ascites.